Literature DB >> 22428852

The unique features of Th9 cells and their products.

Cuiyan Tan1, Igal Gery.   

Abstract

Although it was discovered more than two decades ago, new information concerning the biological activities of IL-9 has been provided in recent years, after the isolation of cells that selectively produce this cytokine, designated "Th9." Th9 cells are generated in vitro by polarization, mainly by TGF-β and IL-4, during activation with the specific antigen, or with anti-CD3/CD28 antibodies. This review deals mainly with Th9 generated by the former, "physiological" mode of activation. Of particular interest is the unique production kinetics of IL-9: the cytokine is produced very rapidly, but after reaching its peak (day 3 in our studies), it declines sharply to trace levels. In addition to IL-9, Th9 cells also produce similar amounts of another cytokine, IL-10, but the production kinetics of these two cytokines are strikingly different. Antigen-activated Th9 in our studies also developed pathogenic capacity, but only during the short time period of peak IL-9 production. Interestingly, no IL-9-producing cells were detected in sites of inflammation induced by Th9, in contrast to Thl and Thl7. The unique features of Th9 cells and their products are discussed with regards to the known and assumed functions of the cytokine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22428852      PMCID: PMC3356583          DOI: 10.1615/critrevimmunol.v32.i1.10

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  48 in total

1.  Interleukin 9: a candidate gene for asthma.

Authors:  N C Nicolaides; K J Holroyd; S L Ewart; S M Eleff; M B Kiser; C R Dragwa; C D Sullivan; L Grasso; L Y Zhang; C J Messler; T Zhou; S R Kleeberger; K H Buetow; R C Levitt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

2.  TGF-β interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells.

Authors:  Catherine Uyttenhove; Frank Brombacher; Jacques Van Snick
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

3.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology.

Authors:  Ulla-Angela Temann; Prabir Ray; Richard A Flavell
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 4.  Th9 and allergic disease.

Authors:  Pejman Soroosh; Taylor A Doherty
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

5.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

6.  Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice.

Authors:  A Gessner; H Blum; M Röllinghoff
Journal:  Immunobiology       Date:  1993-12       Impact factor: 3.144

7.  IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.

Authors:  Jonathan S Dodd; Eda Lum; John Goulding; Roshell Muir; Jacques Van Snick; Peter J M Openshaw
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

8.  An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation.

Authors:  Christoph Wilhelm; Keiji Hirota; Benjamin Stieglitz; Jacques Van Snick; Mauro Tolaini; Katharina Lahl; Tim Sparwasser; Helena Helmby; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2011-10-09       Impact factor: 25.606

9.  IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity.

Authors:  Elizabeth E Forbes; Katherine Groschwitz; J Pablo Abonia; Eric B Brandt; Elizabeth Cohen; Carine Blanchard; Richard Ahrens; Luqman Seidu; Andrew McKenzie; Richard Strait; Fred D Finkelman; Paul S Foster; Klaus I Matthaei; Marc E Rothenberg; Simon P Hogan
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

10.  Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness.

Authors:  U A Temann; G P Geba; J A Rankin; R A Flavell
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  22 in total

Review 1.  IL-9 and Th9 cells: progress and challenges.

Authors:  Picheng Zhao; Xiang Xiao; Rafik M Ghobrial; Xian C Li
Journal:  Int Immunol       Date:  2013-09-11       Impact factor: 4.823

2.  Neutralization of interleukin-9 ameliorates symptoms of experimental autoimmune myasthenia gravis in rats by decreasing effector T cells and altering humoral responses.

Authors:  Xiuhua Yao; Qingfei Kong; Xiaoli Xie; Jinghua Wang; Na Li; Yumei Liu; Bo Sun; Ying Li; Guangyou Wang; Wenjin Li; Siying Qu; Haijun Zhao; Dandan Wang; Xijun Liu; Yao Zhang; Lili Mu; Hulun Li
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

3.  Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling.

Authors:  Jacob S Bowers; Michelle H Nelson; Sreenath Kundimi; Stefanie R Bailey; Logan W Huff; Kristina M Schwartz; David J Cole; Mark P Rubinstein; Chrystal M Paulos
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

Review 4.  IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.

Authors:  Junhui Li; Shuqiu Chen; Xiang Xiao; Yong Zhao; Wenjun Ding; Xian C Li
Journal:  Cytokine Growth Factor Rev       Date:  2017-07-17       Impact factor: 7.638

Review 5.  T cell subsets and their signature cytokines in autoimmune and inflammatory diseases.

Authors:  Itay Raphael; Saisha Nalawade; Todd N Eagar; Thomas G Forsthuber
Journal:  Cytokine       Date:  2014-10-30       Impact factor: 3.861

Review 6.  Transcriptional and epigenetic networks of helper T and innate lymphoid cells.

Authors:  Han-Yu Shih; Giuseppe Sciumè; Amanda C Poholek; Golnaz Vahedi; Kiyoshi Hirahara; Alejandro V Villarino; Michael Bonelli; Remy Bosselut; Yuka Kanno; Stefan A Muljo; John J O'Shea
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

7.  Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.

Authors:  Arnaud Millet; Katherine R Martin; Francis Bonnefoy; Philippe Saas; Julie Mocek; Manal Alkan; Benjamin Terrier; Anja Kerstein; Nicola Tamassia; Senthil Kumaran Satyanarayanan; Amiram Ariel; Jean-Antoine Ribeil; Loïc Guillevin; Marco A Cassatella; Antje Mueller; Nathalie Thieblemont; Peter Lamprecht; Luc Mouthon; Sylvain Perruche; Véronique Witko-Sarsat
Journal:  J Clin Invest       Date:  2015-10-05       Impact factor: 14.808

Review 8.  Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease.

Authors:  Kiyoshi Hirahara; Amanda Poholek; Golnaz Vahedi; Arian Laurence; Yuka Kanno; Joshua D Milner; John J O'Shea
Journal:  J Allergy Clin Immunol       Date:  2013-05       Impact factor: 10.793

9.  Phenotypes of Th lineages generated by the commonly used activation with anti-CD3/CD28 antibodies differ from those generated by the physiological activation with the specific antigen.

Authors:  Cuiyan Tan; Lai Wei; Barbara P Vistica; Guangpu Shi; Eric F Wawrousek; Igal Gery
Journal:  Cell Mol Immunol       Date:  2014-03-03       Impact factor: 11.530

10.  Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.

Authors:  Christoph Schlapbach; Ahmed Gehad; Chao Yang; Rei Watanabe; Emmanuella Guenova; Jessica E Teague; Laura Campbell; Nikhil Yawalkar; Thomas S Kupper; Rachael A Clark
Journal:  Sci Transl Med       Date:  2014-01-15       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.